If you are a Healthcare Professional and you would like to log in to access this content, please click "Login".
You are now leaving the Lilly Medical Web site
Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
the product is not used right away, it should be shaken vigorously
life once withdrawn from vial into syringe:
withdrawn from vial into syringe, the suspension should be used
and physical stability of the suspension in the vials has been
demonstrated for 24 hours at 20-25 °C. From a microbiological
point of view, the product should be used immediately. If not used
immediately, in-use storage times and conditions prior to use are the
responsibility of the user and would normally not be longer than 24
hours at 20-25°C.1
ZypAdhera [summary of product characteristics] Eli Lilly Netherland
B.V., The Netherlands.
Date of Last Review:February 07, 2020
Are you satisfied with this content?
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at firstname.lastname@example.org